Merle Sande

Q: What Schools Are Affiliated With Merle Sande

Merle Sande is affiliated with the following schools: Yale University, University of Virginia, University of Washington, University of California, San Francisco, University of Utah

Merle Sande's AcademicInfluence.com Rankings

Merle Sande

Philosophy

#4783

World Rank

#7428

Historical Rank

#1339

USA Rank

Logic

#2169

World Rank

#3100

Historical Rank

#545

USA Rank

philosophy Degrees

Download Badge

Philosophy

Merle Sande's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Merle Sande Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Merle Alden Sande was a leading American infectious-diseases expert whose early recognition of the looming public health crisis posed by AIDS led to the development of basic protocols for how to handle infected patients. He graduated from Washington State University and received his MD degree from the University of Washington, School of Medicine in Seattle.

(See a Problem?)

Merle Sande's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. (1989) (792)
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. (1979) (757)
Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. (1997) (726)
Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. (1998) (707)
Laboratory medicine in Africa: a barrier to effective health care. (2006) (681)
Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. (1992) (604)
Excessive antibiotic use for acute respiratory infections in the United States. (2001) (536)
Sinusitis of the maxillary antrum. (1975) (345)
Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. (1982) (337)
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. (1975) (288)
Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and Methods (2001) (284)
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. (2008) (282)
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. (1987) (277)
Effect of Probenecid on Cerebrospinal Fluid Concentrations of Penicillin and Cephalosporin Derivatives (1974) (272)
The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. (1992) (257)
The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. (1990) (256)
Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. (1985) (252)
Principles of appropriate antibiotic use for acute pharyngitis in adults: background. (2001) (242)
Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. (1978) (228)
Role of toxigenic and invasive bacteria in acute diarrhea of childhood. (1975) (218)
Etiology and antimicrobial therapy of acute maxillary sinusitis. (1979) (212)
Natural history of disseminated Mycobacterium avium complex infection in AIDS. (1991) (210)
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. (1980) (204)
Principles of Appropriate Antibiotic Use for Acute Rhinosinusitis in Adults: Background (2001) (202)
Staphylococcus aureus Endocarditis: Clinical Manifestations in Addicts and Nonaddicts (1983) (193)
TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICIN (1989) (188)
Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. (1988) (186)
The Medical Management of AIDS (1988) (179)
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. (1975) (167)
Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. (1987) (165)
Uncomplicated Acute Bronchitis (2000) (158)
Principles of Appropriate Antibiotic Use for Treatment of Uncomplicated Acute Bronchitis: Background (2001) (156)
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. (1975) (154)
Etiology and Antimicrobial Treatment of Acute Sinusitis (1981) (152)
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. (1984) (143)
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. (1989) (142)
Sexual harassment in medical training. (1993) (142)
Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. (1979) (142)
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. (1975) (141)
Principles of Appropriate Antibiotic Use for Acute Pharyngitis in Adults: Background (2001) (130)
Combination antibiotic therapy of bacterial endocarditis. (1980) (124)
Antiretroviral Therapy for Adult HIV-lnfected Patients: Recommendations From a State-of-the-Art Conference (1993) (121)
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. (1991) (121)
High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. (2001) (119)
Handbook of Animal Models of Infection: Experimental Models in Antimicrobial Chemotherapy (1999) (117)
Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. (1990) (116)
What will it take to stop physicians from prescribing antibiotics in acute bronchitis? (1995) (114)
Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. (1989) (110)
Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. (1984) (107)
AIDS and the elderly. (1999) (102)
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. (1983) (102)
Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. (1979) (99)
Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits (1986) (97)
Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. (1978) (95)
Infection-control guidelines for patients with the acquired immunodeficiency syndrome (AIDS). (1983) (93)
Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies. (1983) (91)
Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. (1974) (91)
Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus (1986) (91)
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. (2001) (90)
Experimental pneumococcal meningitis: role of leukocytes in pathogenesis (1983) (88)
Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. (1976) (88)
Antibiotic therapy of bacterial meningitis: lessons we've learned. (1981) (86)
Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. (1981) (85)
Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. (1993) (83)
Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. (1988) (83)
The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. (1984) (82)
Acute community-acquired bacterial sinusitis: continuing challenges and current management. (2004) (81)
Bacterial Adherence in the Pathogenesis of Endocarditis (1977) (79)
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis (1990) (78)
Role of the Vegetation in Experimental Streptococcus viridans Endocarditis (1974) (76)
Transmission of hepatitis B without transmission of AIDS by accidental needlestick. (1985) (76)
Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium. (1979) (75)
Sustained bacteremia in patients with prosthetic cardiac valves. (1972) (74)
Identification of procedure-related nosocomial infections in high-risk patients. (1981) (74)
Effect of Rifampin on Nasal Carriage of Staphylococcus aureus (1975) (74)
Pathogenesis of endocarditis. (1985) (73)
Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro (1985) (72)
Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. (1981) (71)
Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis (1984) (70)
Serotypes of Cryptococcus neoformans in patients with AIDS. (1986) (69)
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: Background☆1☆2☆3☆4☆5☆6☆7☆8 (2001) (68)
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits (1985) (66)
Routine use of anaerobic blood cultures: are they still indicated? (2000) (66)
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. (1984) (66)
Experimental models in antimicrobial chemotherapy (1986) (64)
Candida albicans Endocarditis: Ultrastructural Studies of Vegetation Formation (1978) (63)
Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. (1994) (63)
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. (2001) (63)
Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. (1992) (61)
Antimicrobial Therapy of Experimental Enterococcal Endocarditis (1975) (61)
Diarrhea and AIDS in the era of highly active antiretroviral therapy. (1999) (61)
Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. (1984) (60)
Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. (2006) (57)
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus (1984) (55)
Impact of HIV Infection and Kaposi Sarcoma on Human Herpesvirus-8 Mucosal Replication and Dissemination in Uganda (2009) (54)
Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis (1983) (54)
Influenza, Winter Olympiad, 2002 (2006) (54)
Comparative Pharmacology of Cefaclor and Cephalexin (1977) (52)
Ciprofloxacin for Salmonella bacteremia in the acquired immunodeficiency syndrome (AIDS). (1989) (51)
Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin (1992) (50)
Bacteremia associated with cardiac catheterization. (1969) (50)
Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits. (1978) (49)
Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. (1984) (47)
Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency (1981) (45)
Enzyme-linked immunosorbent assay for detection of Streptococcus pneumoniae antigen (1979) (44)
Experimental Candida albicans endocarditis: characterization of the disease and response to therapy (1977) (43)
Ventriculojugular shunt nephritis with Corynebacterium bovis. Successful therapy with antibiotics. (1975) (43)
The Feasibility and Acceptability of Implementing Formal Evaluation Sessions and Using Descriptive Vocabulary to Assess Student Performance on a Clinical Clerkship (2002) (43)
Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis. (1977) (42)
Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases. (1983) (41)
The AIDS Knowledge Base: A Textbook on HIV Disease from the University of California, San Francisco, and the San Francisco General Hospital (1994) (41)
Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits. (1983) (41)
In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice. (1973) (41)
Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis (1979) (39)
Value of serum tests in combined drug therapy of endocarditis (1983) (39)
Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs. (1984) (38)
Rapid identification of pneumococci. Gram stain vs. the quellung reaction. (1973) (38)
The use of rifampin in the treatment of nontuberculous infections: an overview. (1983) (38)
Effect of indomethacin on brain water content, cerebrospinal fluid white blood cell response and prostaglandin E2 levels in cerebrospinal fluid in experimental pneumococcal meningitis in rabbits (1987) (38)
Diagnosis of pneumococcal pneumonia by antigen detection in sputum (1978) (38)
Comparative Pharmacology of Josamycin and Erythromycin Stearate (1976) (37)
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus (1985) (37)
Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. (1986) (37)
Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis (1985) (37)
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects (1981) (36)
The HIV epidemic and training in internal medicine. Challenges and recommendations. (1989) (36)
Pharmacodynamics of Cefazolin in the Presence of Normal and Impaired Renal Function (1973) (36)
Factors influencing the penetration and activity of antibiotics in experimental meningitis. (1981) (36)
Diagnosis and outcome of bowel infarction on an acute medical service. (1983) (36)
Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young. (1981) (36)
Providencia stuartii, a hospital pathogen: potential factors for its emergence and transmission. (1976) (35)
Penetration of antistaphylococcal antibiotics into the human eye. (1974) (35)
Comparison of Netilmicin with Gentamicin in the Therapy of Experimental Escherichia coli Meningitis (1978) (35)
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. (2001) (35)
Cholestasis and disseminated cytomegalovirus disease in patients with the acquired immunodeficiency syndrome. (1988) (35)
Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis. (1977) (35)
Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus (1986) (34)
Leukocyte and bacterial interrelationships in experimental meningitis (1981) (34)
Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. (1996) (34)
Evaluation of cefamandole therapy of patients with bacterial meningitis. (1978) (33)
General principles of therapy of pyogenic meningitis. (1990) (33)
Pharmacokinetics of Cefaclor and Cephalexin: Dosage Nomograms for Impaired Renal Function (1978) (33)
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs (1985) (32)
Fluid administration, brain edema, and cerebrospinal fluid lactate and glucose concentrations in experimental Escherichia coli meningitis. (1993) (32)
Point source epidemic of Mycoplasma pneumoniae infection in a prosthodontics laboratory. (1975) (32)
The Abilities of a Staphylococcus epidermidis Wild-Type Strain and Its Slime-Negative Mutant To Induce Endocarditis in Rabbits Are Comparable (1998) (32)
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction (1980) (32)
The Sanford Guide to HIV/AIDS Therapy (2000) (31)
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. (1992) (30)
Evaluation of pefloxacin in experimental Escherichia coli meningitis (1986) (30)
Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. (1995) (30)
Influence of preformed antibody on experimental Streptococcus sanguis endocarditis (1979) (30)
Effect of indomethacin on the pathophysiology of experimental meningitis in rabbits. (1991) (30)
Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. (1984) (29)
The use of rifampicin in staphylococcal infections--a review. (1984) (29)
Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection. (1985) (29)
Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli. (1977) (29)
Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis (1985) (28)
Pathophysiology of bacterial meningitis: summary of the workshop. (1989) (28)
Detection of circulating antigen in experimental Candida albicans endocarditis by an enzyme-linked immunosorbent assay (1980) (28)
Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. (2007) (27)
Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis (1983) (27)
In Vitro Susceptibility Studies with Josamycin and Erythromycin (1976) (27)
Rolling out antiretrovirals in Africa: there are still challenges ahead. (2005) (26)
The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes. (2007) (26)
Studies of the Chemotherapy of Endocarditis: Correlation of in Vitro, Animal Model, and Clinical Studies (1983) (25)
Novel approaches for the use of aminoglycosides: the value of experimental models. (1986) (25)
Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda (2009) (24)
Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis (1982) (24)
Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis. (1980) (24)
Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel. (1998) (23)
Swine-Influenza Infection in Civilians (1976) (22)
Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. (1985) (22)
New dimensions in antimicrobial therapy (1984) (22)
Mecillinam-Ampicillin Synergism in Experimental Enterobacteriaceae Meningitis (1979) (22)
Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination. (1973) (22)
Summary of a workshop: Pathophysiology of bacterial meningitis—implications for new management strategies (1987) (21)
Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits (1989) (21)
Clinical aspects of adult epiglottitis. (1986) (21)
Principles in the treatment of bacterial meningitis. (1984) (21)
The Prevalence and Causes of Visual Loss Among HIV-Infected Individuals in Uganda (2010) (21)
A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. (1998) (21)
Pulmonary infection with capsule-deficientCryptococcus neoformans (1979) (20)
Current Diagnosis & Treatment in Infectious Diseases (2001) (19)
The pharmacokinetics of teicoplanin in varying degrees of renal function (1990) (19)
Penicillin-netilmicin synergism against Streptococcus faecalis (1978) (19)
Combination antifungal chemotherapy for experimental disseminated candidiasis: lack of correlation between in vitro and in vivo observations with amphotericin B and rifampin. (1983) (18)
Cefamandole in the therapy of experimental pneumococcal meningitis. (1976) (18)
Pathogenesis of bacterial meningitis: Contributions by experimental models in rabbits (2005) (18)
Abdominal aortitis due to Streptococcus pneumoniae and Enterobacter aerogenes (2006) (17)
Methods to improve detection of pneumococci in respiratory secretions (1975) (17)
The influence of fever on the development of experimental Streptococcus pneumoniae meningitis. (1987) (17)
Cerebrospinal fluid prognostic indices in experimental pneumococcal meningitis. (1982) (17)
Contemporary issues in infectious diseases (1984) (17)
Landmark perspective: The impact of penicillin on the treatment of meningitis. (1984) (17)
Challenging conventional aminoglycoside dosing regimens. The value of experimental models. (1986) (17)
Risk of Transmitting the Human Immunodeficiency Virus, Cytomegalovirus, and Hepatitis B Virus to Health Care Workers Exposed to Patients With AIDS and AIDS-Related Conditions (1987) (17)
Cefamandole treatment of pulmonary infection caused by gram-negative rods. (1976) (16)
Treatment of HIV/AIDS: do the dilemmas only increase? (2004) (16)
Dexamethasone in bacterial meningitis: increasing evidence for a beneficial effect (1989) (16)
Emerging resistance to nonnucleoside reverse transcriptase inhibitors: a warning and a challenge. (2002) (15)
Yeast Adherence in the Pathogenesis of Candida Endocarditis 1 (1981) (15)
Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic (2009) (15)
Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia (1987) (15)
Moxalactam therapy vs. standard antimicrobial therapy for selected serious infections. (1982) (15)
In Vitro Susceptibility Studies with Cefaclor and Cephalexin (1977) (14)
Measuring the Outcomes of a Comprehensive HIV Care Course: Pilot Test at the Infectious Diseases Institute, Kampala, Uganda (2006) (14)
Antimicrobial therapy for two serious bacterial infections. Enterococcal endocarditis and nosocomial pneumonia. (1982) (14)
Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysis (1982) (14)
Moxalactam for the treatment of bacterial meningitis in children. (1983) (13)
Pharmacodynamics of antibiotics in experimental bacterial meningitis--two sides to rapid bacterial killing in the cerebrospinal fluid. (1990) (13)
Simultaneous disseminated aspergillosis and zygomycosis in a leukemic patient. (1979) (13)
HIV/AIDS care in Africa today. (2005) (13)
A multivariate approach to prognostication in experimental bacterial meningitis. (1981) (12)
Hemodynamic characteristics of patients with hypothermia due to occult infection and other causes. (1985) (12)
Factors influencing the pathogenesis and prevention of infective endocarditis. (1982) (12)
Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus. (1995) (12)
Ampicillin and an ester in experimental Hemophilus influenzae meningitis (1976) (12)
Evaluation of antimicrobial agents in the rabbit model of endocarditis. (1981) (11)
The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitis. (1985) (11)
Influence of the developmental state of valvular lesions on the antimicrobial activity of cefotaxime in experimental enterococcal infections (1985) (11)
OUTCOMES OF CRYPTOCOCCAL MENINGITIS IN UGANDA BEFORE AND AFTER THE AVAILABILITY OF HAART (2008) (11)
Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (11)
The academic alliance for AIDS care and prevention in Africa. (2008) (11)
Factors influencing the penetration of antimicrobial agents into the cerebrospinal fluid of experimental animals. (1978) (11)
Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. (1987) (11)
Experimental models of CNS infections. Contributions to concepts of disease and treatment. (1986) (10)
Clindamycin therapy of experimental Staphylococcus aureus endocarditis (1982) (10)
In Vitro Antibiotic Susceptibility of Salmonellae (1977) (10)
Role of platelets in endocarditis: clues from von Willebrand disease. (1992) (9)
Report of a second workshop: Pathophysiology of bacterial meningitis. (1989) (9)
Pneumococcal meningitis: current pathophysiologic concepts. (1999) (9)
Globalization: a new dimension for academic internal medicine. (2006) (9)
Swine-influenza infection in civilians. Report of two cases. (1976) (9)
Use of animal models in evaluation of the quinolones. (1988) (8)
Update in Infectious Diseases (2004) (8)
The crisis in infectious diseases (2001) (8)
Antimicrobial activity of gentamicin in experimental enterococcal endocarditis (1985) (8)
Limitations of animal models in predicting beta-lactam efficacy for endocarditis and meningitis. (1986) (8)
Comprar The Sanford Guide to Antimicrobial Therapy 2008 (PDA edition installer CD for Palm, Pocket PC or BlackBerry) | Merle A. Sande | 9781930808553 | Antimicrobial Therapy (2009) (8)
Alterations in cerebrospinal fluid outflow resistance in experimental bacterial meningitis. (1978) (8)
Mechanism of anaemia in experimental bacterial endocarditis. (2009) (7)
Ciprofloxacin in the treatment of Helicobacter pylori in patients with gastritis and peptic ulcer. (1990) (7)
Experimental endocarditis in calf after tricuspid valve replacement. (1980) (7)
Patterns of antibiotic use in a busy metropolitan emergency room: analysis of efficacy and cost-appropriateness. (1983) (7)
Effects of sub-bactericidal concentrations of antibiotics in experimental models of endocarditis. (1985) (7)
Aspiration during sleep. (1973) (6)
Amdinocillin therapy of experimental animal infections. (1983) (6)
The Suspected Infected Prosthetic Joint: Clinical Acumen and Added Value of Laboratory Investigations (2015) (6)
Evaluation of methods for determining antibacterial activity of serum and urine after colistimethate injection (1970) (6)
Comprar The Sanford guide to HIV/AIDS therapy 2008 | David N. Gilbert | 9781930808430 | Antimicrobial Therapy (2008) (6)
Osteomyelitis caused by concurrent infection with Mycobacterium tuberculosis and Blastomyces dermatitidis. (1974) (6)
Antibiotic combinations in experimental infections in animals. (1982) (6)
Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (6)
Bacterial Meningitis: Selected Aspects of Cerebrospinal Fluid Pathophysiology (1983) (6)
Antimicrobial therapy of infections in patients with AIDS--an overview. (1989) (6)
Tuberculosis and human immunodeficiency virus disease. (1994) (6)
Antibiotic penetration into normal and inflamed tissues as reflected by peripheral lymph. (1979) (5)
Bacterial Meningitis: Changes in Cerebrospinal Fluid Outflow Resistance (1980) (5)
Induction and Maintenance Therapy for Opportunistic Infections in Patients with AIDS (1989) (5)
Special Report: Infection-Control Guidelines for Patients with the Acquired Immunodeficiency Syndrome (AIDS) (1984) (4)
Cefotetan and coagulopathy. (1989) (4)
Double-Blind Comparison of Carbenicillin Indanyl Sodium, Ampicillin, and Cephalexin in Treatment of Urinary Tract Infection (1973) (4)
Single-dose ampicillin/sulbactam versus ceftriaxone as treatment for uncomplicated gonorrhoea in a Ugandan STD clinic population with a high prevalence of PPNG infection. (1995) (4)
InVitro Susceptibility Studies withJosamycin and Erythromycin (1976) (3)
Experimental models in antimicrobial chemotherapy. Volume 2. (1986) (3)
The use of rifampin in the treatment of nontuberculous infections. Symposium held in San Francisco, California April 1982. (1983) (3)
NewCephalosporins Cefotaxime, Cefpimizole, BMY 28142, andHR 810inExperimental Pneumococcal Meningitis inRabbits (1985) (3)
Serotypes of Cryptococcus neoformans in Patients (1986) (3)
Evaluation of new anti-infective drugs for the treatment of cryptococcal meningitis. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (3)
Cryptococcosis and other fungal infections (histoplasmosis and coccidioidomycosis) in HIV-infected patients (2008) (3)
Some newer aspects of infective endocarditis. (1975) (3)
Evaluation of new anti-infective drugs for the treatment of viral encephalitis. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (3)
Postgraduate training in infectious diseases. (2006) (2)
A 32-year-old man with the acquired immunodeficiency syndrome and pneumococcal meningitis. (1987) (2)
The Sanford guide to HIV/AIDS therapy 2008 (2008) (2)
The public health risk of emerging and reemerging infections. (1996) (2)
Otitis media: a review. (1977) (2)
Complications of Bacterial Meningitis (1990) (2)
Comparative Pharmacology ofJosamycin andErythromycin Stearate (1976) (2)
Inhibition of isolation of Escherichia coli in blood cultures by trimethoprim-sulfamethoxazole. (1983) (2)
Bacterial adherence in endocarditis: interaction of bacterial dextran, platelets, fibrin, and antibody. (1980) (2)
Human immunodeficiency virus infection (1994) (2)
Developing strategies for the future of academic public hospitals. (1996) (2)
Health care reform: implications for professions related to infectious diseases. (1994) (2)
Treatment of Serious Infections in the 1990s (1991) (2)
The need for controlled clinical studies in antimicrobial therapy. (1978) (2)
Ciprofloxacin in the treatment of acute infectious diarrhea (1989) (1)
Infection with human immunodeficiency virus, an epidemic out of control: personal reflections. (1999) (1)
Antibiotic penetration into normal and inflamed tissues as reflected by peripheral lymph. (1977) (1)
NIAID Recommendations for Treating HIV Infection-Reply (1994) (1)
Combined Flucytosine — Amphotericin B Treatment of Cryptococcosis (1976) (1)
Parasitic infections continued. (1988) (1)
Symposium on host-parasite interactions. Umeå, Sweden, June 6-8, 1979. (1980) (1)
Diagnosis of Pneumococcal Pneumonia by Antigen Detection (1)
Oral SCH 39304 as primary, salvage, and maintenance therapy for cryptococcal meningitis in AIDS. (1992) (1)
Cryptococcal meningitis in the acquired immunodeficiency syndrome. (1990) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; management of infections associated with HIV immunodeficiency (1989) (0)
Cardiovascular Involvement in Acquired Immune Deficiency Syndrome (2007) (0)
Effect ofRifampin onNasalCarriage ofStaphylococcus aureus (1975) (0)
Editorial overview (1989) (0)
The Jeremiah Metzger lecture: the terrible impact of AIDS on Africa--the case for prevention & treatment now. (2004) (0)
Studies examining the relative role of FAI in HIV / AIDS patients with sepsis and other severe illnesses (2007) (0)
Prospective Randomized Trial of Naloxone versus Dopamine as Adjunctive Therapy for Bacteremic Shock. (1984) (0)
Serum Bactericidal Activity of Rifampin (0)
AIDS: An introduction. (1988) (0)
Influence ofBodyTemperature on Bacterial GrowthRatesin Experimental Pneumococcal Meningitis inRabbits (1986) (0)
Antiretroviral Drugs for Millions (2006) (0)
Teicoplanin Versus Nafcillin andVancomycin intheTreatment of Experimental Endocarditis CausedbyMethicillin-Susc (1984) (0)
Making drugs work against HIV. (1996) (0)
The AIDS epidemic: blueprint of a hospital's response. (1988) (0)
Chapter 29 – Cryptococcosis and other fungal infections (histoplasmosis and coccidioidomycosis) in HIV-infected patients (2012) (0)
Controversies in the diagnosis and management of infectious diseases. Session III: AIDS. Summary and discussion. (1986) (0)
Current concepts of infectious diseasesp. (1977) (0)
ValueofSerumTests inCombinedDrugTherapy of Endocarditis (1983) (0)
Treatment of serious infections in the 1990s continued. (1992) (0)
HIV infection and AIDS: Editorial Overview (1991) (0)
Acute bronchitis in the healthy adult. (2000) (0)
Comprar Guía Sanford de terapéutica antimicrobiana 2009 | Merle A. Sande | 9789507624056 | AWWE (2010) (0)
Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae. (1989) (0)
Pharmacodynamics ofCefazolin inthePresence ofNormalandImpaired RenalFunction (1973) (0)
Serum bactericidal titer as a predictor of outcome in endocarditis (1986) (0)
Reply to Lawn and Wood (2006) (0)
Infectious Diseases Society of America and health care reform. (1994) (0)
New cephalosporin antibiotics: selection and uses. (1985) (0)
Pefloxacin Therapy forExperimental Endocarditis Causedby Methicillin-Susc eptible (1985) (0)

This paper list is powered by the following services:

Other Resources About Merle Sande

en.wikipedia.org

What Schools Are Affiliated With Merle Sande?

Merle Sande is affiliated with the following schools:

Merle Sande's Academic­Influence.com Rankings